“…A recent study has shown that women affected with MS had lower live birth rates (LBR) compared to unaffected women (irrespective of their infertility diagnosis or treatment) (Houtchens et al, 2020). This statistically significant difference in LBRs was more evident in women in early (Bauer-Mehren et al, 2011;Profaizer and Eckels, 2012;Leone et al, 2013;Chattopadhyay et al, 2014;Mosaad, 2015;Pinero et al, 20152015;Robinson et al, 2015;Piñero et al, 2017;Wieczorek et al, 2017;Jongsma et al, 2019;Piñero et al, 2020;Tersigni et al, 2020;Wilczyńska et al, 2020) and middle (Emmery et al, 2016;Nielsen et al, 2017;Agius et al, 2018;Papúchová et al, 2019) childbearing years. The difference between women with and without MS disappeared after receiving infertility treatments, thus highlighting the importance of information regarding the efficacy of infertility treatments in women with autoimmune diseases (Houtchens et al, 2020).…”